172 related articles for article (PubMed ID: 22068616)
21. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
Liu Z; Li J; Zeng Z; Liu M; Wang M
Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
[TBL] [Abstract][Full Text] [Related]
22. Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells.
Nakatsuji H; Maeda N; Hibuse T; Hiuge A; Hirata A; Kuroda Y; Kishida K; Kihara S; Funahashi T; Shimomura I
Biochem Biophys Res Commun; 2010 Jan; 392(1):100-5. PubMed ID: 20059960
[TBL] [Abstract][Full Text] [Related]
23. Effects of fatty acid regulation on visfatin gene expression in adipocytes.
Wen Y; Wang HW; Wu J; Lu HL; Hu XF; Cianflone K
Chin Med J (Engl); 2006 Oct; 119(20):1701-8. PubMed ID: 17097017
[TBL] [Abstract][Full Text] [Related]
24. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
25. Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus.
Ruge T; Sukonina V; Kroupa O; Makoveichuk E; Lundgren M; Svensson MK; Olivecrona G; Eriksson JW
Metabolism; 2012 May; 61(5):652-60. PubMed ID: 22078753
[TBL] [Abstract][Full Text] [Related]
26. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice.
Xu A; Lam MC; Chan KW; Wang Y; Zhang J; Hoo RL; Xu JY; Chen B; Chow WS; Tso AW; Lam KS
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6086-91. PubMed ID: 15837923
[TBL] [Abstract][Full Text] [Related]
27. Improving glycogenesis in Streptozocin (STZ) diabetic mice after administration of green algae Chlorella.
Cherng JY; Shih MF
Life Sci; 2006 Feb; 78(11):1181-6. PubMed ID: 16289560
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of lipoprotein lipase in 3T3-L1 adipocytes by angiopoietin-like protein 4 requires that both proteins have reached the cell surface.
Makoveichuk E; Vorrsjö E; Olivecrona T; Olivecrona G
Biochem Biophys Res Commun; 2013 Nov; 441(4):941-6. PubMed ID: 24220340
[TBL] [Abstract][Full Text] [Related]
29. Effects of guggulsterone isolated from Commiphora mukul in high fat diet induced diabetic rats.
Sharma B; Salunke R; Srivastava S; Majumder C; Roy P
Food Chem Toxicol; 2009 Oct; 47(10):2631-9. PubMed ID: 19635521
[TBL] [Abstract][Full Text] [Related]
30. The acute phase response stimulates the expression of angiopoietin like protein 4.
Lu B; Moser A; Shigenaga JK; Grunfeld C; Feingold KR
Biochem Biophys Res Commun; 2010 Jan; 391(4):1737-41. PubMed ID: 20043872
[TBL] [Abstract][Full Text] [Related]
31. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
[TBL] [Abstract][Full Text] [Related]
32. Angiopoietin-like 2, a circadian gene, improves type 2 diabetes through potentiation of insulin sensitivity in mice adipocytes.
Kitazawa M; Nagano M; Masumoto KH; Shigeyoshi Y; Natsume T; Hashimoto S
Endocrinology; 2011 Jul; 152(7):2558-67. PubMed ID: 21586562
[TBL] [Abstract][Full Text] [Related]
33. Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats.
Guo QY; Miao LN; Li B; Ma FZ; Liu N; Cai L; Xu ZG
Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E708-16. PubMed ID: 21285403
[TBL] [Abstract][Full Text] [Related]
34. Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats.
Bi Y; Sun WP; Chen X; Li M; Liang H; Cai MY; Zhu YH; He XY; Xu F; Weng JP
Acta Diabetol; 2008 Sep; 45(3):167-78. PubMed ID: 18500427
[TBL] [Abstract][Full Text] [Related]
35. Anti-diabetic effects of emodin involved in the activation of PPARgamma on high-fat diet-fed and low dose of streptozotocin-induced diabetic mice.
Xue J; Ding W; Liu Y
Fitoterapia; 2010 Apr; 81(3):173-7. PubMed ID: 19699280
[TBL] [Abstract][Full Text] [Related]
36. Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids.
Huber J; Löffler M; Bilban M; Reimers M; Kadl A; Todoric J; Zeyda M; Geyeregger R; Schreiner M; Weichhart T; Leitinger N; Waldhäusl W; Stulnig TM
Int J Obes (Lond); 2007 Jun; 31(6):1004-13. PubMed ID: 17130847
[TBL] [Abstract][Full Text] [Related]
37. ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilizes independent pathways.
Korecka A; de Wouters T; Cultrone A; Lapaque N; Pettersson S; Doré J; Blottière HM; Arulampalam V
Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G1025-37. PubMed ID: 23518684
[TBL] [Abstract][Full Text] [Related]
38. Angiopoietin Like Protein 2 (ANGPTL2) Promotes Adipose Tissue Macrophage and T lymphocyte Accumulation and Leads to Insulin Resistance.
Sasaki Y; Ohta M; Desai D; Figueiredo JL; Whelan MC; Sugano T; Yamabi M; Yano W; Faits T; Yabusaki K; Zhang H; Mlynarchik AK; Inoue K; Mizuno K; Aikawa M
PLoS One; 2015; 10(7):e0131176. PubMed ID: 26132105
[TBL] [Abstract][Full Text] [Related]
39. The C-terminal fibrinogen-like domain of angiopoietin-like 4 stimulates adipose tissue lipolysis and promotes energy expenditure.
McQueen AE; Kanamaluru D; Yan K; Gray NE; Wu L; Li ML; Chang A; Hasan A; Stifler D; Koliwad SK; Wang JC
J Biol Chem; 2017 Sep; 292(39):16122-16134. PubMed ID: 28842503
[TBL] [Abstract][Full Text] [Related]
40. Antidiabetic, antihyperlipidemic and anti-inflammatory effects of tilianin in streptozotocin-nicotinamide diabetic rats.
García-Díaz JA; Navarrete-Vázquez G; García-Jiménez S; Hidalgo-Figueroa S; Almanza-Pérez JC; Alarcón-Aguilar FJ; Gómez-Zamudio J; Cruz M; Ibarra-Barajas M; Estrada-Soto S
Biomed Pharmacother; 2016 Oct; 83():667-675. PubMed ID: 27470567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
